CALGARY, Alberta, Oct. 20, 2021 – Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”), (CSE: MGW) and (OTCQB: MGWFD), is excited to unveil the Company’s new health and wellness brand, RèNao Wellness. This brand is dedicated to offering consumers a healthy and natural wellness experience, utilizing the benefits provided by CBG, CBG enhanced with patented nano technology, and other cannabinoids. The brand will carry an expertly tailored line of high-quality health and wellness products, including tinctures, topicals, and capsules.
RèNao is a Mandarin word that translates to lively, prosperous, and flourishing. RèNao Wellness was created to provide these same attributes through a line of health and wellness products. This new brand will be replacing the Company’s Maple Leaf Green World and Golden State Green World consumer brands. The RèNao Wellness logo and label design can be viewed below or click here: https://bit.ly/3piwLfh.
“The RèNao Wellness branding and messaging reinforces Maple Leaf’s goal of delivering high quality cannabinoid products to our customers.” said Raymond Lai, Maple Leaf’s President and Chief Executive Officer. “RèNao Wellness, paired with our existing recreational brand Phoenix Crave, is part of our strategy to grow our consumer base and revenue streams. We are excited to begin launching products under the RèNao Wellness brand over the coming weeks.”
In order to accelerate Maple Leaf’s growth and distribution footprint, the Company is examining a multitude of opportunities to get these products in the hands of consumers across the United States through online, retail, and wholesale channels.
For further information and updates regarding the Company, please visit https://www.mlgreenworld.com/.
For updates regarding the California CBG Hemp Project, please visit https://www.gsgreenworld.com/.
About Maple Leaf Green World Inc.
Maple Leaf is a public Canadian company that is focused on the hemp industry in North America. The Company currently has a hemp project in Southern California. With over 10 years of extensive greenhouse management experience, the Company applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free cannabis products. Maple Leaf’s long-term objective is to produce cannabis oil and to export its products to approved countries. The Company’s common shares are listed for trading on the Canadian Securities Exchange (“CSE”) under the symbol “MGW” and on the OTCQB market under the symbol “MGWFD.”
Forward Looking and Cautionary Statements
This news release may include forward-looking statements including opinions, assumptions, estimates, the Company’s assessment of future plans and operations, and, more particularly, statements concerning: the Proposed Transaction and the timing thereof; When used in this document, the words “will,” “anticipate,” “believe,” “estimate,” “expect,” “intent,” “may,” “project,” “should,” and similar expressions are intended to be among the statements that identify forward-looking statements. The forward-looking statements are founded on the basis of expectations and assumptions made by the Company that include, but are not limited to, the timely receipt of all required regulatory and third-party approvals, including approvals from the CSE and from the shareholders of Maple Leaf. Forward-looking statements are subject to a wide range of risks and uncertainties, and although the Company believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will be realized. Any number of important factors could cause actual results to differ materially from those in the forward-looking statements including, but not limited to: regulatory and third party approvals, including approvals from the CSE and from the shareholders of Maple Leaf, not being obtained in the manner or timing anticipated; the ability to implement corporate strategies; the state of domestic capital markets; the ability to obtain financing; changes in general market conditions; industry conditions and events; and other factors more fully described from time to time in the reports and filings made by the Company with securities regulatory authorities. Please refer to the Company’s annual information form (“AIF”) for the year ended December 31, 2020 and management’s discussion and analysis (“MD&A”) thereof for additional risk factors relating to the Company. The AIF and MD&A can be accessed under the Company’s profile on www.sedar.com.
Except as required by applicable laws, the Company does not undertake any obligation to publicly update or revise any forward-looking statements.
For further information, please contact: